ArticleFrontiers in immunology2023

Brensocatib (an oral, reversible inhibitor of dipeptidyl peptidase-1) attenuates disease progression in two animal models of rheumatoid arthritis.

Patrick P McDonald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.